816 related articles for article (PubMed ID: 15651349)
1. [Corticobasal degeneration and atypical progressive supranuclear palsy: their symptomatology, laboratory examination and differential diagnosis].
Morimatsu M; Negoro K; Mori H
Rinsho Shinkeigaku; 2004 Nov; 44(11):982-5. PubMed ID: 15651349
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP.
Josephs KA; Petersen RC; Knopman DS; Boeve BF; Whitwell JL; Duffy JR; Parisi JE; Dickson DW
Neurology; 2006 Jan; 66(1):41-8. PubMed ID: 16401843
[TBL] [Abstract][Full Text] [Related]
3. [A 65-year-old man with rigid-bradykinetic parkinsonism, vertical gaze palsy, difficulty of eye-lid opening, and marked pseudo-bulbar palsy].
Noda K; Kobayashi T; Matsuoka S; Takanashi M; Kanazawa A; Mizuno Y
No To Shinkei; 2005 Jan; 57(1):73-86. PubMed ID: 15782604
[TBL] [Abstract][Full Text] [Related]
4. Behavior and cognition in corticobasal degeneration and progressive supranuclear palsy.
Kertesz A; McMonagle P
J Neurol Sci; 2010 Feb; 289(1-2):138-43. PubMed ID: 19733862
[TBL] [Abstract][Full Text] [Related]
5. Magnetic resonance imaging-based volumetry differentiates progressive supranuclear palsy from corticobasal degeneration.
Gröschel K; Hauser TK; Luft A; Patronas N; Dichgans J; Litvan I; Schulz JB
Neuroimage; 2004 Feb; 21(2):714-24. PubMed ID: 14980574
[TBL] [Abstract][Full Text] [Related]
6. The many faces of corticobasal degeneration.
Wadia PM; Lang AE
Parkinsonism Relat Disord; 2007; 13 Suppl 3():S336-40. PubMed ID: 18267261
[TBL] [Abstract][Full Text] [Related]
7. [Corticobasal degeneration].
Mizusawa H
Rinsho Shinkeigaku; 1997 Dec; 37(12):1131-3. PubMed ID: 9577668
[TBL] [Abstract][Full Text] [Related]
8. Distribution of astrocytic plaques in the corticobasal degeneration brain and comparison with tuft-shaped astrocytes in the progressive supranuclear palsy brain.
Hattori M; Hashizume Y; Yoshida M; Iwasaki Y; Hishikawa N; Ueda R; Ojika K
Acta Neuropathol; 2003 Aug; 106(2):143-9. PubMed ID: 12732936
[TBL] [Abstract][Full Text] [Related]
9. Progressive supranuclear palsy and corticobasal degeneration: lumping versus splitting.
Scaravilli T; Tolosa E; Ferrer I
Mov Disord; 2005 Aug; 20 Suppl 12():S21-8. PubMed ID: 16092076
[TBL] [Abstract][Full Text] [Related]
10. Does corticobasal degeneration exist? A clinicopathological re-evaluation.
Ling H; O'Sullivan SS; Holton JL; Revesz T; Massey LA; Williams DR; Paviour DC; Lees AJ
Brain; 2010 Jul; 133(Pt 7):2045-57. PubMed ID: 20584946
[TBL] [Abstract][Full Text] [Related]
11. [Corticobasal degeneration and progressive supranuclear palsy--differentiation by somatosensory-evoked potentials].
Miwa H; Mori H; Abe K; Hoshino I; Mizuno Y
No To Shinkei; 1996 Mar; 48(3):253-7. PubMed ID: 8868336
[TBL] [Abstract][Full Text] [Related]
12. [The diagnostic challenge of corticobasal degeneration: distinction between clinical syndrome and pathology].
Kellner O; Sabova K; Neumann M; Jung HH
Fortschr Neurol Psychiatr; 2011 Nov; 79(11):660-7. PubMed ID: 22009274
[TBL] [Abstract][Full Text] [Related]
13. [An autopsy case of corticobasal degeneration without prominent cortical pathology--an imitator of progressive supranuclear palsy].
Hattori M; Yoshida M; Ojika K; Yuasa H; Mitake S; Hashizume Y
Rinsho Shinkeigaku; 2000 Apr; 40(4):372-7. PubMed ID: 10967656
[TBL] [Abstract][Full Text] [Related]
14. [Neuroimaging features in progressive supranuclear palsy and corticobasal degeneration].
Mori E
Rinsho Shinkeigaku; 2002 Nov; 42(11):1158-61. PubMed ID: 12784693
[TBL] [Abstract][Full Text] [Related]
15. [A case manifested overlapping neuropathologic features of both progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD)].
Inagaki T; Seno HI; Iijima M; Nagai A; Bokura H; Kobayashi S; Wada M; Harada T
No To Shinkei; 1998 Mar; 50(3):263-71. PubMed ID: 9566003
[TBL] [Abstract][Full Text] [Related]
16. [Progressive supranuclear palsy: what's new?].
Levy R
Geriatr Psychol Neuropsychiatr Vieil; 2011 Jun; 9(2):191-201. PubMed ID: 21690028
[TBL] [Abstract][Full Text] [Related]
17. Discrepancy between clinical and pathological diagnoses of CBD and PSP.
Mizuno T; Shiga K; Nakata Y; Nagura J; Nakase T; Ueda Y; Takanashi Y; Urasaki K; Oyamada Y; Fushiki S; Nishikawa J; Yasuhara M; Nakajima K; Nakagawa M
J Neurol; 2005 Jun; 252(6):687-97. PubMed ID: 15754090
[TBL] [Abstract][Full Text] [Related]
18. [Provisional diagnostic criteria of corticobasal degeneration (CBD) and the survey of patients with CBD in Japan].
Morimatsu M; Negoro K
Rinsho Shinkeigaku; 2002 Nov; 42(11):1150-3. PubMed ID: 12784691
[TBL] [Abstract][Full Text] [Related]
19. Apraxia of speech and nonfluent aphasia: a new clinical marker for corticobasal degeneration and progressive supranuclear palsy.
Josephs KA; Duffy JR
Curr Opin Neurol; 2008 Dec; 21(6):688-92. PubMed ID: 18989114
[TBL] [Abstract][Full Text] [Related]
20. Increased tau burden in the cortices of progressive supranuclear palsy presenting with corticobasal syndrome.
Tsuboi Y; Josephs KA; Boeve BF; Litvan I; Caselli RJ; Caviness JN; Uitti RJ; Bott AD; Dickson DW
Mov Disord; 2005 Aug; 20(8):982-8. PubMed ID: 15834857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
